Groupama Asset Managment purchased a new position in shares of Globe Life Inc. (NYSE:GL - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 16,374 shares of the company's stock, valued at approximately $1,800,000.
Several other hedge funds have also added to or reduced their stakes in GL. Private Trust Co. NA lifted its holdings in shares of Globe Life by 12.5% during the fourth quarter. Private Trust Co. NA now owns 754 shares of the company's stock worth $84,000 after buying an additional 84 shares in the last quarter. HighPoint Advisor Group LLC increased its position in Globe Life by 4.0% in the 4th quarter. HighPoint Advisor Group LLC now owns 2,271 shares of the company's stock valued at $276,000 after acquiring an additional 87 shares during the period. Pinnacle Wealth Planning Services Inc. raised its position in Globe Life by 4.0% during the 4th quarter. Pinnacle Wealth Planning Services Inc. now owns 2,293 shares of the company's stock worth $256,000 after purchasing an additional 88 shares during the last quarter. EverSource Wealth Advisors LLC raised its stake in Globe Life by 32.7% during the fourth quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company's stock worth $41,000 after buying an additional 90 shares during the last quarter. Finally, New Mexico Educational Retirement Board lifted its stake in shares of Globe Life by 2.4% in the 4th quarter. New Mexico Educational Retirement Board now owns 4,233 shares of the company's stock valued at $472,000 after purchasing an additional 100 shares during the period. Institutional investors and hedge funds own 81.61% of the company's stock.
Insider Activity at Globe Life
In related news, CEO Frank M. Svoboda sold 11,000 shares of the company's stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $122.31, for a total transaction of $1,345,410.00. Following the sale, the chief executive officer now owns 18,948 shares of the company's stock, valued at approximately $2,317,529.88. This represents a 36.73 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO James Matthew Darden sold 24,890 shares of Globe Life stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $121.52, for a total transaction of $3,024,632.80. Following the sale, the chief executive officer now owns 38,973 shares of the company's stock, valued at approximately $4,735,998.96. The trade was a 38.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.51% of the stock is currently owned by company insiders.
Globe Life Stock Down 2.7 %
GL stock traded down $3.22 during trading on Monday, reaching $114.01. The stock had a trading volume of 478,628 shares, compared to its average volume of 1,412,626. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $9.49 billion, a price-to-earnings ratio of 9.53 and a beta of 0.60. Globe Life Inc. has a one year low of $38.95 and a one year high of $133.76. The company's 50 day moving average is $124.89 and its two-hundred day moving average is $114.82.
Globe Life (NYSE:GL - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. Equities research analysts forecast that Globe Life Inc. will post 13.87 EPS for the current year.
Globe Life Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Thursday, April 3rd will be paid a $0.27 dividend. This is a boost from Globe Life's previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a yield of 0.95%. The ex-dividend date is Thursday, April 3rd. Globe Life's payout ratio is currently 9.04%.
Analysts Set New Price Targets
A number of research firms have commented on GL. Jefferies Financial Group raised their price target on shares of Globe Life from $107.00 to $114.00 and gave the stock a "hold" rating in a report on Tuesday, December 10th. Wells Fargo & Company increased their price objective on shares of Globe Life from $126.00 to $141.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 19th. JPMorgan Chase & Co. raised their target price on Globe Life from $136.00 to $145.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Morgan Stanley upped their price target on Globe Life from $125.00 to $126.00 and gave the stock an "equal weight" rating in a research note on Friday, February 28th. Finally, Keefe, Bruyette & Woods raised their price objective on Globe Life from $137.00 to $145.00 and gave the company an "outperform" rating in a research note on Wednesday, February 12th. Five research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Globe Life has an average rating of "Moderate Buy" and an average price target of $138.45.
View Our Latest Stock Report on Globe Life
Globe Life Profile
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Further Reading

Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.